Abstract:Tuberculosis (TB) is a major health threat to the human population worldwide. The etiology of the disease is Mycobacterium tuberculosis (Mtb), a highly successful intracellular pathogen. It has the ability to manipulate the host immune response and to make the intracellular environment suitable for its survival. Many studies have addressed the interactions between the bacteria and the host immune cells as involving many immune mediators and other cellular players. Interferon-β (IFN-β) signaling is crucial for inducing the host innate immune response and it is an important determinant in the fate of mycobacterial infection. The role of IFN-β in protection against viral infections is well established and has been studied for decades, but its role in mycobacterial infections remains much more complicated and debatable. The involvement of IFN-β in immune evasion mechanisms adopted by Mtb has been an important area of investigation in recent years. These advances have widened our understanding of the pro-bacterial role of IFN-β in host–pathogen interactions. This pro-bacterial activity of IFN-β appears to be correlated with its anti-inflammatory characteristics, primarily by antagonizing the production and function of interleukin 1β (IL-1β) and interleukin 18 (IL-18) through increased interleukin 10 (IL-10) production and by inhibiting the nucleotide-binding domain and leucine-rich repeat protein-3 (NLRP3) inflammasome. Furthermore, it also fails to provoke a proper T helper 1 (Th1) response and reduces the expression of major histocompatibility complex II (MHC-II) and interferon-γ receptors (IFNGRs). Here we will review some studies to provide a paradigm for the induction, regulation, and role of IFN-β in mycobacterial infection. Indeed, recent studies suggest that IFN-β plays a role in Mtb survival in host cells and its downregulation may be a useful therapeutic strategy to control Mtb infection.

Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases

Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections

Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: A review of current understanding

Type I interferon responses contribute to immune protection against mycobacterial infection

The immune characterization of interferon-β responses in tuberculosis patients

Innate Type 1 Immune Response, but Not IL-17 Cells Control Tuberculosis Infection.

The Crucial Roles of Th17-related Cytokines/signal Pathways in M. Tuberculosis Infection

Autologous host-pathogen pairing enhances early immune responses and bacterial growth control in tuberculosis in vitro granuloma model

IFN-β: A Contentious Player in Host–Pathogen Interaction in Tuberculosis

Type I interferon and bacterial infection]

Interleukin-1 receptor antagonist mediates type I interferon-driven susceptibility to Mycobacterium tuberculosis

Type 1 interferon expression and signaling occur in distinct regions in granulomas during Mycobacterium tuberculosis infection

Recent advances in understanding the human host immune response in tuberculous meningitis

Lipid Peroxidation and Type I Interferon Coupling Fuels Pathogenic Macrophage Activation Causing Tuberculosis Susceptibility

Immunopathology in human tuberculosis

Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis

Increased Frequencies of T Helper Type 17 Cells in Tuberculous Pleural Effusion.

Type I Interferon Suppresses Type II Interferon–Triggered Human Anti-Mycobacterial Responses

High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL-17 against M. tuberculosis antigen

Mycobacterium tuberculosis inhibits autocrine type I interferon signaling to increase intracellular survival

Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis